Development of Guidelines for Monitoring Drug Allergies and Adverse Drug Reactions at Hadsamran Hospital Commemorating His Majesty the King's 80th Birthday Anniversary, Trang Province
Keywords:
Drug allergy, Adverse drug reactions, Drug monitoringAbstract
This research aimed to develop a drug allergy and adverse drug reaction surveillance guideline at Hadsamran Hospital Commemorating His Majesty the King's 80th Birthday Anniversary, Trang Province. The study employed was survey research by retrospective design using a lesson-learned process, incorporating both quantitative and qualitative methods from January 1, 2024, to March 31, 2024. The quantitative sample consisted of 140 patients with a history of drug allergies and adverse drug reactions between October 1, 2022, and September 30, 2023. Qualitative data was collected from 20 medical personnel and patients using purposive sampling. Data collection tools included hospital medical records, questionnaires, semi-structured interviews, and observation notes. Data analysis utilized descriptive statistics and content analysis.
The research findings revealed that the developed guideline, named "Drug Allergy Management and Monitoring System" (DAMMS MODEL), was a comprehensive drug allergy surveillance and management system covering detection, assessment, monitoring, management, and safety. After implementation, the proportion of detected drug allergy cases increased from 18.56% to 31.43%, while the proportion of patients with adverse drug reactions decreased from 81.44% to 68.57%. This system improved data recording and reporting completeness and prevented recurrent allergic reactions.
References
สำนักงานคณะกรรมการอาหารและยา กระทรวงสาธารณสุข. นโยบายแห่งชาติด้านยาและยุทธศาสตร์การพัฒนาระบบยาแห่งชาติ พ.ศ. 2563-2565 [อินเทอร์เน็ต]. นนทบุรี: สำนักงานคณะกรรมการอาหารและยา; 2563 [เข้าถึงเมื่อวันที่ 4 เมษายน 2566]. เข้าถึงได้จาก: https://ndp.fda.moph.go.th/ndi/policy-ndi-detail-1.
Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PloS one. 2021;16(7):e0254707.
Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and strategies in guideline implementation—a scoping review. Healthcare. 2021;6(3):1-25.
Hickson RP, et al. Medication use in older adults with and without a drug-related inpatient encounter. Journal of the American Geriatrics Society. 2001;49(8):1071-1076.
Kaufman G. Adverse drug reactions: a review of practical considerations. British Journal of Nursing. 2015;24(10):529-536.
Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. The Annals of Pharmacotherapy. 2008;42(7):1017-1025.
Lee F, Chan H, Wong H. Effectiveness of drug allergy card to prevent repeated prescribing of allergenic medications in a Malaysian public hospital. Pharmacoepidemiol Drug Saf. 2019; 28:760-1. https://doi.org/10.1002/pds.4780
Quiralte J, et al. Hipersensibilidad a antiinflamatorios no esteroideos. Allergologia et Immunopathologia. 2004;32(5):233-242.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.
Benjamin D. Reducing Medication Errors and Increasing Patient Safety: Case Studies in Clinical Pharmacology. The Journal of Clinical Pharmacology. 2003;43. Available from: https://doi.org/10.1177/0091270003254794.
Sung T, Hung F, Chiu H. Implementation of an integrated drug information system for inpatients to reduce medication errors in the administrating stage. 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2008:743-746. Available from: https://doi.org/10.1109/IEMBS.2008.4649259.
ธนัฎชา สองเมือง, อนัญญา สองเมือง. โปรแกรมคอมพิวเตอร์บันทึกแจ้งเตือนรายการยาที่ผู้ป่วยมีประวัติอาการไม่พึงประสงค์ในงานบริการเภสัชกรรม. วารสารวิชาการสาธารณสุข. 2564;30(4):734-42.
Sakunrag I. การพัฒนาระบบคอมพิวเตอร์เพื่อแจ้งเตือนการแพ้ยาร่วมกับการจัดการฐานข้อมูลการแพ้ยาของโรงพยาบาลแห่งหนึ่งในจังหวัดสมุทรสาคร [อินเทอร์เน็ต]. ResearchGate; 2019 [เข้าถึงเมื่อวันที่ cite date]. เข้าถึงได้จาก: https://www.researchgate.net/publication/332554088
Rodríguez-Monguió R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug reactions. Pharmacoeconomics. 2003;21(9):623-50.
Lipworth BJ. Pharmacokinetics of inhaled drugs. British Journal of Clinical Pharmacology. 2011;71(3):379-399.
Rodríguez-Monguió R, et al. Assessing the economic impact of adverse drug reactions. Pharmacoeconomics. 2003;21(9):623-650.
Shrestha R, Khan G, Thapa P, Koju R. Study of the side effects profile of different antihypertensive drugs among the hypertensive patient. Nepalese Heart J. 2013;9:25-9. https://doi.org/10.3126/NJH.V9I1.8344
Doña I, Blanca-López N, Torres MJ, García-Campos J, García-Núñez I, Gómez F, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol. 2012;22(5):363-71.
Pokladnikova J, Meyboom R, Meincke R, Niedrig D, Russmann S. Allergy-like immediate reactions with herbal medicines: a retrospective study using data from VigiBase®. Drug Saf. 2016;39(5):455-64.
Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US emergency department visits for outpatient adverse drug events, 2013-2014. Jama. 2019;322(20):2018-2028.
